Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomes.
Chao M, Spencer S, Guerrieri M, Ding W, Goharian M, Ho H, Ng M, Healey D, Tan A, Cham C, Joon DL, Lawrentschuk N, Travis D, Sengupta S, Chan Y, Troy A, Pham T, Clarke D, Liodakis P, Bolton D. Chao M, et al. Among authors: troy a. J Contemp Brachytherapy. 2018 Apr;10(2):155-161. doi: 10.5114/jcb.2018.75600. Epub 2018 Apr 30. J Contemp Brachytherapy. 2018. PMID: 29789764 Free PMC article. Review.
High dose rate brachytherapy boost for prostate cancer: Biochemical control and the impact of transurethral resection of the prostate and hydrogel spacer insertion on toxicity outcomes.
Chao M, Bolton D, Lim Joon D, Chan Y, Lawrentschuk N, Ho H, Spencer S, Wasiak J, Guerrieri M, Ow D, Troy A, Pham T, Sengupta S, Tan A, McMillan K, Koufogiannis G, Foroudi F, Ng M, Khoo V. Chao M, et al. Among authors: troy a. J Med Imaging Radiat Oncol. 2019 Jun;63(3):415-421. doi: 10.1111/1754-9485.12882. Epub 2019 Mar 25. J Med Imaging Radiat Oncol. 2019. PMID: 30908894
Mini PCNL for renal calculi: does size matter?
Hennessey DB, Kinnear NK, Troy A, Angus D, Bolton DM, Webb DR. Hennessey DB, et al. Among authors: troy a. BJU Int. 2017 May;119 Suppl 5:39-46. doi: 10.1111/bju.13839. BJU Int. 2017. PMID: 28544299
Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer.
Anton A, Kamel Hasan O, Ballok Z, Bowden P, Costello AJ, Harewood L, Corcoran NM, Dundee P, Peters JS, Lawrentschuk N, Troy A, Webb D, Chan Y, See A, Siva S, Murphy D, Hofman MS, Tran B. Anton A, et al. Among authors: troy a. BJU Int. 2020 Oct;126(4):433-435. doi: 10.1111/bju.15151. Epub 2020 Aug 4. BJU Int. 2020. PMID: 32579772 No abstract available.
129 results